VMP 39731511000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Aliskiren 300mg tablets
BNF code 0205053A0AAABAB
Virtual Therapeutic Moiety Aliskiren
Date identifier became valid 27 May 2021
Previous product identifier 425669009
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Aliskiren hemifumarate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 426725002
Strength value numerator 300.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Rasilez 300mg tablets (CST Pharma Ltd)
Rasilez 300mg tablets (Lexon (UK) Ltd)
Rasilez 300mg tablets (Noden Pharma DAC)
Rasilez 300mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Aliskiren 300mg tablets 28 tablet
Aliskiren 300mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.0.0_20241104000001, imported on 5th November 2024 at 03:47:41.

Feedback